News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
317,013 Results
Type
Article (15729)
Company Profile (293)
Press Release (300980)
Multimedia
Podcasts (66)
Webinars (12)
Section
Business (91696)
Career Advice (163)
Deals (16211)
Drug Delivery (38)
Drug Development (53789)
Employer Resources (31)
FDA (6917)
Job Trends (5562)
News (165380)
Policy (12344)
Tag
Academia (963)
Accelerated approval (8)
Adcomms (14)
Allergies (74)
Alliances (26197)
ALS (94)
Alzheimer's disease (1017)
Antibody-drug conjugate (ADC) (153)
Approvals (7019)
Artificial intelligence (188)
Autoimmune disease (43)
Automation (9)
Bankruptcy (111)
Best Places to Work (4796)
BIOSECURE Act (6)
Biosimilars (84)
Biotechnology (235)
Bladder cancer (82)
Brain cancer (34)
Breast cancer (264)
Cancer (2355)
Cardiovascular disease (180)
Career advice (145)
Career pathing (3)
CAR-T (167)
CDC (5)
Cell therapy (448)
Cervical cancer (12)
Clinical research (45145)
Collaboration (865)
Company closure (2)
Compensation (449)
Complete response letters (31)
COVID-19 (1162)
CRISPR (73)
C-suite (350)
Cystic fibrosis (94)
Data (2841)
Denatured (13)
Depression (71)
Diabetes (213)
Diagnostics (1783)
Digital health (6)
Diversity (4)
Diversity, equity & inclusion (9)
Drug discovery (130)
Drug pricing (37)
Drug shortages (3)
Duchenne muscular dystrophy (170)
Earnings (35424)
Editorial (21)
Employer branding (4)
Employer resources (29)
Events (54105)
Executive appointments (598)
FDA (8293)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (11)
Funding (757)
Gene editing (140)
Generative AI (12)
Gene therapy (384)
GLP-1 (476)
Government (1241)
Grass and pollen (3)
Guidances (161)
Healthcare (7149)
HIV (12)
Huntington's disease (32)
IgA nephropathy (50)
Immunology and inflammation (147)
Immuno-oncology (8)
Indications (34)
Infectious disease (1248)
Inflammatory bowel disease (140)
Inflation Reduction Act (9)
Influenza (35)
Intellectual property (128)
Interviews (18)
IPO (8164)
IRA (12)
Job creations (1044)
Job search strategy (136)
Kidney cancer (8)
Labor market (16)
Layoffs (238)
Leadership (5)
Legal (2147)
Liver cancer (47)
Longevity (8)
Lung cancer (345)
Lymphoma (168)
Machine learning (14)
Management (7)
Manufacturing (279)
MASH (99)
Medical device (3567)
Medtech (3573)
Mergers & acquisitions (8591)
Metabolic disorders (583)
Multiple sclerosis (89)
NASH (13)
Neurodegenerative disease (135)
Neuropsychiatric disorders (42)
Neuroscience (1710)
NextGen: Class of 2025 (2142)
Non-profit (897)
Now hiring (27)
Obesity (264)
Opinion (111)
Ovarian cancer (99)
Pain (75)
Pancreatic cancer (115)
Parkinson's disease (176)
Partnered (10)
Patents (236)
Patient recruitment (198)
Peanut (40)
People (28749)
Pharmaceutical (47)
Pharmacy benefit managers (7)
Phase I (15594)
Phase II (20805)
Phase III (13569)
Pipeline (1709)
Policy (77)
Postmarket research (992)
Preclinical (6569)
Press Release (32)
Prostate cancer (109)
Psychedelics (46)
Radiopharmaceuticals (229)
Rare diseases (443)
Real estate (1889)
Recruiting (12)
Regulatory (10787)
Reports (22)
Research institute (995)
Resumes & cover letters (17)
Rett syndrome (10)
RNA editing (15)
RSV (14)
Schizophrenia (100)
Series A (138)
Series B (103)
Service/supplier (1)
Sickle cell disease (57)
Special edition (16)
Spinal muscular atrophy (118)
Sponsored (13)
Startups (2199)
State (1)
Stomach cancer (6)
Supply chain (30)
Tariffs (16)
The Weekly (52)
Vaccines (310)
Venture capital (45)
Weight loss (144)
Women's health (18)
Worklife (2)
Date
Today (68)
Last 7 days (310)
Last 30 days (1478)
Last 365 days (19374)
2025 (14285)
2024 (21855)
2023 (23967)
2022 (30248)
2021 (31137)
2020 (26589)
2019 (18341)
2018 (13441)
2017 (15635)
2016 (13739)
2015 (16811)
2014 (12452)
2013 (9312)
2012 (9526)
2011 (9706)
2010 (9313)
Location
Africa (201)
Alabama (57)
Alaska (2)
Arizona (65)
Arkansas (5)
Asia (30769)
Australia (4476)
California (5666)
Canada (1648)
China (655)
Colorado (199)
Connecticut (211)
Delaware (165)
Europe (45840)
Florida (714)
Georgia (177)
Hawaii (2)
Idaho (16)
Illinois (329)
India (26)
Indiana (132)
Iowa (7)
Japan (236)
Kansas (76)
Kentucky (6)
Louisiana (4)
Maine (13)
Maryland (662)
Massachusetts (4581)
Michigan (94)
Minnesota (231)
Mississippi (3)
Missouri (28)
Montana (14)
Nebraska (4)
Nevada (30)
New Hampshire (15)
New Jersey (1464)
New Mexico (12)
New York (1498)
North Carolina (725)
North Dakota (6)
Northern California (2608)
Ohio (146)
Oklahoma (11)
Oregon (23)
Pennsylvania (1056)
Puerto Rico (8)
Rhode Island (26)
South America (275)
South Carolina (6)
Southern California (2217)
Tennessee (32)
Texas (704)
United States (19314)
Utah (87)
Virginia (115)
Washington D.C. (37)
Washington State (471)
West Virginia (1)
Wisconsin (32)
317,013 Results for "modex therapeutics ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development
June 10, 2025
·
7 min read
Press Releases
Tenpoint Therapeutics, Ltd. to Participate in Investor Conferences in September 2025
August 25, 2025
·
1 min read
Press Releases
OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck
January 7, 2025
·
5 min read
Press Releases
Tenpoint Therapeutics Ltd. to Participate in Upcoming Investor Conferences in August 2025
August 5, 2025
·
2 min read
Business
Nona Biosciences Enters into Antibody Discovery Agreement with OPKO Health’s ModeX Therapeutics
Nona Biosciences today announced it has entered into an agreement with ModeX Therapeutics, an OPKO Health company, for the use of Nona’s platforms to support ModeX’s development of multispecific antibody therapeutics.
May 23, 2023
·
3 min read
Press Releases
Lobe Sciences Ltd. and Cynaptec Pharmaceuticals, Inc. to Present a New Therapeutic Approach for the Treatment of Chronic Cluster Headaches at Clusterbusters 2025
September 10, 2025
·
6 min read
Drug Development
AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of HIV
ModeX Therapeutics Inc., an OPKO Health company, announced results from a Phase 1 clinical study of SAR441236, its trispecific broadly neutralizing antibody against the human immunodeficiency virus, at the 2024 Conference on Retroviruses and Opportunistic Infections in Denver, Colorado.
March 5, 2024
·
6 min read
Press Releases
ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million to Initiate Influenza Program
October 7, 2024
·
7 min read
Press Releases
OPKO Health’s ModeX Therapeutics Appoints Dr. Giovanni Abbadessa as Chief Medical Officer as Pipeline Advances into Clinical Development
September 24, 2024
·
4 min read
Press Releases
OPKO Health’s ModeX Therapeutics Secures $35 Million BARDA Supplement to Develop COVID Multispecific Antibodies and $16 Million toInitiate Influenza Program
October 9, 2024
·
1 min read
1 of 31,702
Next
